214 related articles for article (PubMed ID: 25197016)
1. MiR-107 and miR-99a-3p predict chemotherapy response in patients with advanced colorectal cancer.
Molina-Pinelo S; Carnero A; Rivera F; Estevez-Garcia P; Bozada JM; Limon ML; Benavent M; Gomez J; Pastor MD; Chaves M; Suarez R; Paz-Ares L; de la Portilla F; Carranza-Carranza A; Sevilla I; Vicioso L; Garcia-Carbonero R
BMC Cancer; 2014 Sep; 14():656. PubMed ID: 25197016
[TBL] [Abstract][Full Text] [Related]
2. Molecular pathogenesis of breast cancer: impact of miR-99a-5p and miR-99a-3p regulation on oncogenic genes.
Shinden Y; Hirashima T; Nohata N; Toda H; Okada R; Asai S; Tanaka T; Hozaka Y; Ohtsuka T; Kijima Y; Seki N
J Hum Genet; 2021 May; 66(5):519-534. PubMed ID: 33177704
[TBL] [Abstract][Full Text] [Related]
3. MTUS1 and its targeting miRNAs in colorectal carcinoma: significant associations.
Ozcan O; Kara M; Yumrutas O; Bozgeyik E; Bozgeyik I; Celik OI
Tumour Biol; 2016 May; 37(5):6637-45. PubMed ID: 26643896
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA expression profiling identifies miR-31-5p/3p as associated with time to progression in wild-type RAS metastatic colorectal cancer treated with cetuximab.
Mlcochova J; Faltejskova-Vychytilova P; Ferracin M; Zagatti B; Radova L; Svoboda M; Nemecek R; John S; Kiss I; Vyzula R; Negrini M; Slaby O
Oncotarget; 2015 Nov; 6(36):38695-704. PubMed ID: 26497852
[TBL] [Abstract][Full Text] [Related]
5. Circulating Plasma Levels of miR-20b, miR-29b and miR-155 as Predictors of Bevacizumab Efficacy in Patients with Metastatic Colorectal Cancer.
Ulivi P; Canale M; Passardi A; Marisi G; Valgiusti M; Frassineti GL; Calistri D; Amadori D; Scarpi E
Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29361687
[TBL] [Abstract][Full Text] [Related]
6. A specific microRNA profile as predictive biomarker for systemic treatment in patients with metastatic colorectal cancer.
Poel D; Gootjes EC; Bakkerus L; Trypsteen W; Dekker H; van der Vliet HJ; van Grieken NCT; Verhoef C; Buffart TE; Verheul HMW
Cancer Med; 2020 Oct; 9(20):7558-7571. PubMed ID: 32864858
[TBL] [Abstract][Full Text] [Related]
7. High expression of microRNA-625-3p is associated with poor response to first-line oxaliplatin based treatment of metastatic colorectal cancer.
Rasmussen MH; Jensen NF; Tarpgaard LS; Qvortrup C; Rømer MU; Stenvang J; Hansen TP; Christensen LL; Lindebjerg J; Hansen F; Jensen BV; Hansen TF; Pfeiffer P; Brünner N; Ørntoft TF; Andersen CL
Mol Oncol; 2013 Jun; 7(3):637-46. PubMed ID: 23506979
[TBL] [Abstract][Full Text] [Related]
8. Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer.
Zhang J; Raju GS; Chang DW; Lin SH; Chen Z; Wu X
Cancer; 2018 Feb; 124(4):785-796. PubMed ID: 29112225
[TBL] [Abstract][Full Text] [Related]
9. Hsa-miR-31-3p expression is linked to progression-free survival in patients with KRAS wild-type metastatic colorectal cancer treated with anti-EGFR therapy.
Manceau G; Imbeaud S; Thiébaut R; Liébaert F; Fontaine K; Rousseau F; Génin B; Le Corre D; Didelot A; Vincent M; Bachet JB; Chibaudel B; Bouché O; Landi B; Bibeau F; Leroy K; Penault-Llorca F; Van Laethem JL; Demetter P; Tejpar S; Rossi S; Mosakhani N; Osterlund P; Ristamäki R; Sarhadi V; Knuutila S; Boige V; André T; Laurent-Puig P
Clin Cancer Res; 2014 Jun; 20(12):3338-47. PubMed ID: 24771647
[TBL] [Abstract][Full Text] [Related]
10. Combination of a six microRNA expression profile with four clinicopathological factors for response prediction of systemic treatment in patients with advanced colorectal cancer.
Neerincx M; Poel D; Sie DLS; van Grieken NCT; Shankaraiah RC; van der Wolf-de Lijster FSW; van Waesberghe JTM; Burggraaf JD; Eijk PP; Verhoef C; Ylstra B; Meijer GA; van de Wiel MA; Buffart TE; Verheul HMW
PLoS One; 2018; 13(8):e0201809. PubMed ID: 30075027
[TBL] [Abstract][Full Text] [Related]
11. Expression levels of miR-143-3p and -424-5p in colorectal cancer and their clinical significance.
Sahami-Fard MH; Kheirandish S; Sheikhha MH
Cancer Biomark; 2019; 24(3):291-297. PubMed ID: 30883340
[TBL] [Abstract][Full Text] [Related]
12. The association of miR-126-3p, miR-126-5p and miR-664-3p expression profiles with outcomes of patients with metastatic colorectal cancer treated with bevacizumab.
Fiala O; Pitule P; Hosek P; Liska V; Sorejs O; Bruha J; Vycital O; Buchler T; Poprach A; Topolcan O; Finek J
Tumour Biol; 2017 Jul; 39(7):1010428317709283. PubMed ID: 28714375
[TBL] [Abstract][Full Text] [Related]
13. Plasma microRNAs predicting clinical outcome in metastatic colorectal cancer patients receiving first-line oxaliplatin-based treatment.
Kjersem JB; Ikdahl T; Lingjaerde OC; Guren T; Tveit KM; Kure EH
Mol Oncol; 2014 Feb; 8(1):59-67. PubMed ID: 24119443
[TBL] [Abstract][Full Text] [Related]
14. Screening and preliminary validation of miRNAs with the regulation of hTERT in colorectal cancer.
Qin YZ; Xie XC; Liu HZ; Lai H; Qiu H; Ge LY
Oncol Rep; 2015 Jun; 33(6):2728-36. PubMed ID: 25845814
[TBL] [Abstract][Full Text] [Related]
15. Serum-based microRNA signature predicts relapse and therapeutic outcome of adjuvant chemotherapy in colorectal cancer patients.
Ji D; Qiao M; Yao Y; Li M; Chen H; Dong Q; Jia J; Cui X; Li Z; Xia J; Gu J
EBioMedicine; 2018 Sep; 35():189-197. PubMed ID: 30166271
[TBL] [Abstract][Full Text] [Related]
16. An Independent Validation Study of Candidate microRNAs as Predictive Biomarkers for Bevacizumab-based Therapy in Patients With Metastatic Colorectal Cancer.
Kiss D; Machackova T; Souckova K; Fabian P; Krepelkova I; Svoboda M; Kiss I
In Vivo; 2021; 35(5):2809-2814. PubMed ID: 34410972
[TBL] [Abstract][Full Text] [Related]
17. Disruption of the c-Myc/miR-200b-3p/PRDX2 regulatory loop enhances tumor metastasis and chemotherapeutic resistance in colorectal cancer.
Lv Z; Wei J; You W; Wang R; Shang J; Xiong Y; Yang H; Yang X; Fu Z
J Transl Med; 2017 Dec; 15(1):257. PubMed ID: 29258530
[TBL] [Abstract][Full Text] [Related]
18. Up-regulation of the expressions of MiR-149-5p and MiR-99a-3p in exosome inhibits the progress of pituitary adenomas.
Zhao P; Cheng J; Li B; Nie D; Li C; Gui S; Wang H; Zhang Y
Cell Biol Toxicol; 2021 Aug; 37(4):633-651. PubMed ID: 33400021
[TBL] [Abstract][Full Text] [Related]
19.
Mizuno K; Tanigawa K; Nohata N; Misono S; Okada R; Asai S; Moriya S; Suetsugu T; Inoue H; Seki N
Cells; 2020 Sep; 9(9):. PubMed ID: 32932948
[TBL] [Abstract][Full Text] [Related]
20. Expression of miR-18a-5p, miR-144-3p, and miR-663b in colorectal cancer and their association with cholesterol homeostasis.
Sharma B; Randhawa V; Vaiphei K; Gupta V; Dahiya D; Agnihotri N
J Steroid Biochem Mol Biol; 2021 Apr; 208():105822. PubMed ID: 33465419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
